AnaptysBio Inc buy Wells Fargo & Company
Start price
12.12.24
/
50%
€14.40
Target price
12.12.25
€38.17
Performance (%)
159.72%
End price
13.12.25
€37.40
Summary
This prediction ended on 13.12.25 with a price of €37.40. The BUY prediction by Wells_Fargo___Compan for AnaptysBio Inc saw massive gains of 159.72%. Wells_Fargo___Compan has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | -10.741% | -10.741% | 181.871% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by Wells_Fargo___Compan for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Wells Fargo & Company from $56.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten